Navigation Links
LV Series Miniature Stepper Motors from Parker Hannifin Corporation

ProductsLV Series Miniature Stepper Motors from Parker Hannifin Corporation
Company Parker Hannifin Corporation
Item LV Series Miniature Stepper Motors
Price Inquire
Description The LV Series offers high performance miniature stepper motors available in NEMA 11, 14, 17, 23, and 34 frame sizes. These space-efficient 1.8 2-phase stepper motors are perfect for life science applications, including medical instrumentation, medical devices, drug discovery instrumentation, and other miniature automation systems.
  • Meets a wide range of customer needs with its compact size, low voltage, and high torque density
  • Compatible with Parkers ViX-IM stepper drive controller, as well as with other industry standard drives
  • Customized motor windings and cabling available
Info Parker Hannifin CorporationParker Hannifin Corporation
242 Neck Road
Haverhill, MA 01835
Customer Service: (800) 343-4048
Fax Number: (978) 556-7510
Web Site: http://www.parker.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. LX80 Series Precision Stages from Parker Hannifin Corporation
2. 7500 Series ICP-MS ChemStation Upgrade from Agilent Technologies
3. Agilent 1200 Series HPLC-Chip/MS System from Agilent Technologies
4. Staccato Custom Series from Caliper Life Sciences
5. Printer Paper for Model 680 Series Readers, 2 rolls from Bio-Rad
6. The Discovery Series PDQuest Version Upgrade from Bio-Rad
7. Agilent 1200 Series Nanoflow LC System for MS from Agilent Technologies
8. ProteinChip System, Series 4000 from Ciphergen
9. LS Series Microarray Laser Scanner from Tecan
10. Cytomics FC 500 Series Flow Cytometry Systems from Beckman Coulter
11. Cytomics FC 500 Series Flow Cytometry Systems from Beckman Coulter
Human IL-19 MAb (Clone 152112)...
... Allen (1995) This book contains ... on current issues relating to the aetiology ... advances have been made recently which greatly ... include molecular neuropathology through clinical and diagnostic ...
Complement C1r [Human]...
... Beacon Designer designs oligos for SYBR ... beacon, NASBA and FRET assays. Highly specific ... found by automatically interpreting BLAST search results. ... secondary structures identified by connecting to the ...
Biology Products:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology: